Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.73
Delayed Data
As of Mar 29
 +0.01 / +1.39%
Today’s Change
0.27
Today|||52-Week Range
1.02
+101.46%
Year-to-Date
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.72
Today’s open0.73
Day’s range0.65 - 0.76
Volume47,467
Average volume (3 months)140,652
Market cap$19.4M
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)+28.00%
Earnings growth (this year)+3.70%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.76

Competitors

No competitors data available.

Financials

Last reporting dateMarch 30, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$13.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
William D. Schwieterman
Chief Financial Officer
Matthew M. Loar
Corporate headquarters
South San Francisco, California

Forecasts

Chart unavailable

Search for Jobs